AU2001291040A1 - Substituted imidazoles as dual histamine h1 and h3 agonists or antagonists - Google Patents

Substituted imidazoles as dual histamine h1 and h3 agonists or antagonists

Info

Publication number
AU2001291040A1
AU2001291040A1 AU2001291040A AU9104001A AU2001291040A1 AU 2001291040 A1 AU2001291040 A1 AU 2001291040A1 AU 2001291040 A AU2001291040 A AU 2001291040A AU 9104001 A AU9104001 A AU 9104001A AU 2001291040 A1 AU2001291040 A1 AU 2001291040A1
Authority
AU
Australia
Prior art keywords
agonists
antagonists
substituted imidazoles
dual histamine
histamine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001291040A
Other languages
English (en)
Inventor
Adriano Afonso
Robert G Aslanian
Andrew T. Lupo Jr.
John J. Piwinski
Neng-Yang Shih
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Sharp and Dohme LLC
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of AU2001291040A1 publication Critical patent/AU2001291040A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Child & Adolescent Psychology (AREA)
  • Cardiology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Transplantation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
AU2001291040A 2000-09-20 2001-09-18 Substituted imidazoles as dual histamine h1 and h3 agonists or antagonists Abandoned AU2001291040A1 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US23403800P 2000-09-20 2000-09-20
US60/234,038 2000-09-20
US60234038 2000-09-20
PCT/US2001/029037 WO2002024657A2 (en) 2000-09-20 2001-09-18 Substituted imidazoles as dual histamine h1 and h3 agonists or antagonists

Publications (1)

Publication Number Publication Date
AU2001291040A1 true AU2001291040A1 (en) 2002-04-02

Family

ID=22879621

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001291040A Abandoned AU2001291040A1 (en) 2000-09-20 2001-09-18 Substituted imidazoles as dual histamine h1 and h3 agonists or antagonists

Country Status (14)

Country Link
US (1) US6528522B2 (enExample)
EP (1) EP1318993B1 (enExample)
JP (1) JP2004509869A (enExample)
CN (1) CN1558907A (enExample)
AR (1) AR031612A1 (enExample)
AT (1) ATE405557T1 (enExample)
AU (1) AU2001291040A1 (enExample)
CA (1) CA2422210C (enExample)
DE (1) DE60135471D1 (enExample)
ES (1) ES2311544T3 (enExample)
HK (1) HK1052180A1 (enExample)
MX (1) MXPA03002445A (enExample)
MY (1) MY120281A (enExample)
WO (1) WO2002024657A2 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013151982A1 (en) 2012-04-03 2013-10-10 Arena Pharmaceuticals, Inc. Methods and compounds useful in treating pruritus, and methods for identifying such compounds
WO2014130534A1 (en) * 2013-02-19 2014-08-28 Icahn School Of Medicine At Mount Sinai Tricyclic heterocycles as anticancer agents
US9675587B2 (en) 2013-03-14 2017-06-13 Allergan Holdings Unlimited Company Opioid receptor modulator dosage formulations
CA2997769A1 (en) 2015-09-09 2017-03-16 Icahn School Of Medicine At Mount Sinai Heterocyclic constrained tricyclic sulfonamides as anti-cancer agents
CN108349961B (zh) 2015-09-09 2022-02-18 西奈山伊坎医学院 杂环受限三环磺酰胺作为抗癌试剂

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2586562B1 (fr) 1985-09-02 1989-03-10 Inst Nat Sante Rech Med Composition pharmaceutique contenant de l'a-methylhistamine
GB8916947D0 (en) 1989-07-25 1989-09-13 Smith Kline French Lab Medicaments
DK0448765T3 (da) 1990-03-30 1994-09-19 Heumann Pharma Gmbh & Co Anvendelse af guanidinderivater til fremstilling af et lægemiddel med NPY-antagonistisk virkning
GB9115740D0 (en) 1991-07-20 1991-09-04 Smithkline Beecham Plc Medicaments
WO1993012093A1 (en) 1991-12-18 1993-06-24 Schering Corporation Imidazolyl-alkyl-piperazine and -diazepine derivatives as histamine h3 agonists/antagonists
US5352707A (en) 1992-03-26 1994-10-04 Harbor Branch Oceanographic Institution, Inc. Method for treating airway congestion
NZ330898A (en) 1993-11-15 2000-01-28 Schering Corp Phenyl-alkyl imidazoles as H3-receptor antagonists in particular for the treatment of inflammation
FR2732017B1 (fr) * 1995-03-21 2000-09-22 Inst Nat Sante Rech Med Nouveaux derives de l'imidazole antagonistes et/ou agonistes du recepteur h3 de l'histamine, leur preparation et leurs applications therapeutiques
PT1019050E (pt) 1997-06-24 2002-09-30 Novo Nordisk As Utilizacao de agonisticos e de antagonisticos de somatostatina para o tratamento de doencas associadas ao olho
US5869479A (en) 1997-08-14 1999-02-09 Schering Corporation Treatment of upper airway allergic responses

Also Published As

Publication number Publication date
CN1558907A (zh) 2004-12-29
CA2422210A1 (en) 2002-03-28
MY120281A (en) 2005-09-30
JP2004509869A (ja) 2004-04-02
EP1318993A2 (en) 2003-06-18
EP1318993B1 (en) 2008-08-20
AR031612A1 (es) 2003-09-24
MXPA03002445A (es) 2003-06-19
US6528522B2 (en) 2003-03-04
HK1052180A1 (zh) 2003-09-05
WO2002024657A3 (en) 2002-07-11
ATE405557T1 (de) 2008-09-15
WO2002024657A2 (en) 2002-03-28
US20020082272A1 (en) 2002-06-27
CA2422210C (en) 2009-10-27
DE60135471D1 (de) 2008-10-02
ES2311544T3 (es) 2009-02-16

Similar Documents

Publication Publication Date Title
EP1206262A4 (en) Y NEUROPEPTID ANTAGONISTS: SPIROISOQUINOLINONE DERIVATIVES
AU3956900A (en) Substituted imidazoles, their preparation and use
ZA200107917B (en) Bicyclic heteroaromatic compounds useful as LH agonists.
AU2002341834A1 (en) Antagonists
AU2001234128A1 (en) Novel imidazoline compounds
MXPA03000939A (es) Derivados de imidazol.
AU2002336273A1 (en) Heterocyclic compounds and their use as histamine h4 ligands.
GC0000318A (en) Imidazole derivatives
AU3033100A (en) Substituted imidazoles, their preparation and use
AU2002223501A1 (en) Glucagon antagonists/inverse agonists
AU4729699A (en) Imidazo-pyridines, -pyridazines, and -triazines as corticotropin releasing factor antagonists
AU2001264657A1 (en) Crf receptor antagonists
AU2002223500A1 (en) Glucagon antagonists/inverse agonists
AU2002216314A1 (en) Heterocyclic angiogenesis inhibitors
AU4331500A (en) Pyrazolotriazines as crf antagonists
AU2002241459A1 (en) Substituted imidazoles as dual histamine h1 and h3 agonists or antagonists
AU2001244088A1 (en) Condensed imidazoles as histamine h3 receptor ligands
AU2001292730A1 (en) Substituted imidazoles as dual histamine h1 and h3 agonists or antgonists
AU5338699A (en) Imidazoles and related compounds as alpha1a agonists
AU2001291040A1 (en) Substituted imidazoles as dual histamine h1 and h3 agonists or antagonists
AU2001292723A1 (en) Substituted imidazoles as dual histamine h1 and h3 agonists or antagonists
AU2001276354A1 (en) Hetaryl-substituted heterocycles
AU2001263288A1 (en) Crf receptor antagonists
AU2912600A (en) Substituted bicyclic heterocycles and the use thereof as thrombin inhibitors
AU2002224772A1 (en) Morphinoid derivatives as delta-opioid agonists and antagonists